Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications
- PMID: 19953334
- DOI: 10.1245/s10434-009-0812-y
Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications
Abstract
Background: We assessed the effect of T stage, Fuhrman's grade, multifocality, bilaterality, positive surgical margins, and synchronism of bilateral tumors on cancer-specific survival of patients with nonmetastatic renal-cell carcinoma (RCC) undergoing nephron-sparing surgery for imperative indications.
Methods: We retrospectively analyzed 168 patients who underwent nephron-sparing surgery for imperative RCC indications between 1974 and 2002. A total of 85 patients had bilateral RCCs; in 27 patients, the tumors were multifocal. Multivariate Cox proportional hazards models were fitted to assess the features associated with cancer-specific survival.
Results: The median follow-up was 99 months (range, 2-326 months). Patients were followed until January 2008. A total of 52 patients died of their cancer during follow-up. Multivariate analyses of the total group only revealed Fuhrman's grade 3 (hazard ratio [HR] 2.94) and bilateral occurrence of RCC (HR 1.82) as independent prognostic factors. In a subgroup analysis of patients with bilateral occurrence of RCC, we observed a tendency toward positive surgical margins (HR 2.89, P = 0.08) being another negative prognostic factor. There was no difference in cancer-specific survival between patients with synchronous and metachronous bilateral RCC presence (HR 1.08).
Conclusions: Fuhrman's grade 3 and bilateral occurrence of RCC were the only statistically significant prognostic factors for cancer-specific survival in patients undergoing nephron-sparing surgery for imperative indications for nonmetastatic RCC. The presence of sporadic multifocal tumors and the synchronous occurrence of bilateral tumors have no influence on cancer-specific survival, while positive surgical margins may have an impact in the subset of patients with bilateral RCC.
Comment in
-
Renal cell carcinoma and prognostic factors predictive of survival.Ann Surg Oncol. 2010 Feb;17(2):362-3. doi: 10.1245/s10434-009-0817-6. Ann Surg Oncol. 2010. PMID: 19908098 Free PMC article. No abstract available.
Similar articles
-
Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.Eur Urol. 2006 Feb;49(2):308-13. doi: 10.1016/j.eururo.2005.10.020. Epub 2005 Dec 9. Eur Urol. 2006. PMID: 16359779
-
Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.BJU Int. 2007 Jul;100(1):26-9. doi: 10.1111/j.1464-410X.2007.06899.x. BJU Int. 2007. PMID: 17552949
-
Outcome of nephron-sparing surgery for T1b renal cell carcinoma.BJU Int. 2009 May;103(10):1344-8. doi: 10.1111/j.1464-410X.2008.08230.x. Epub 2008 Nov 25. BJU Int. 2009. PMID: 19040528
-
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016. Urology. 2004. PMID: 15351571 Review.
-
[Surgical treatment for renal cell carcinoma].Dtsch Med Wochenschr. 2010 Feb;135(6):245-9. doi: 10.1055/s-0029-1244841. Epub 2010 Feb 2. Dtsch Med Wochenschr. 2010. PMID: 20127609 Review. German.
Cited by
-
Renal cell carcinoma and prognostic factors predictive of survival.Ann Surg Oncol. 2010 Feb;17(2):362-3. doi: 10.1245/s10434-009-0817-6. Ann Surg Oncol. 2010. PMID: 19908098 Free PMC article. No abstract available.
-
Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.BMC Cancer. 2021 Jan 19;21(1):79. doi: 10.1186/s12885-021-07795-8. BMC Cancer. 2021. PMID: 33468079 Free PMC article.
-
Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences.World J Surg Oncol. 2014 Aug 8;12:252. doi: 10.1186/1477-7819-12-252. World J Surg Oncol. 2014. PMID: 25103683 Free PMC article. Review.
-
[Structure of biobanks for urological research].Urologe A. 2015 Sep;54(9):1256-60. doi: 10.1007/s00120-014-3722-y. Urologe A. 2015. PMID: 25503899 Review. German.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical